✦ LIBER ✦

346 Cisplatin (P), ifosfamide (I), prolonged oral etoposide (E), and concurrent accelerated hyperfractionated thoracic radiotherapy (TRT) for patients with limited small cell lung cancer (LSCLC): Preliminary results of a phase II trial

✍ Scribed by Glisson, B.; Scott, C.; Komaki, R.; Movsas, B.; Wagner, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-62 Phase II trial of irinotecan plus c

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P-792 Phase II study of cisplatin plus e

✍ Samantas, E.; Syrigos, K.; Briassoulis, E.; Bamias, A.; Koutras, A.; Karina, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB